| 560 |
delayed |
estrus
(GO:0060209)
|
|
None
|
| 559 |
disrupted |
abnormal ovulation
(MP:0001928)
|
|
1074: interruption, Ovulation
|
| 558 |
increased |
|
adenosquamous carcinoma
(MESH:D018196)
|
1070: Increased, adenosquamous carcinomas of endometrium
|
| 557 |
increased |
hyperplasia
(MESH:D006965)
|
glandular epithelial cell
(CL:0000150)
|
2 Events
|
| 556 |
morphological change |
|
Metaplasia
(MESH:D008679)
|
None
|
| 555 |
increased |
cell proliferation
(GO:0008283)
|
basal cell
(CL:0000646)
|
1067: Proliferation/Clonal Expansion, aberrant basal-type cells
|
| 554 |
increased |
gene expression
(GO:0010467)
|
homeobox protein SIX1
(PR:000014896)
|
2329: Sine oculis homeobox 1 gene expression, increased
|
| 553 |
increased |
intracellular estrogen receptor signaling pathway
(GO:0030520)
|
estrogen receptor alpha complex
(PR:000027727)
|
1065: Activation, estrogen receptor alpha
|
| 552 |
increased |
cell proliferation
(GO:0008283)
|
acinar cell
(CL:0000622)
|
1062: Increased, Cellular proliferation / hyperplasia of acinar cells
|
| 551 |
increased |
|
cholecystokinin
(PR:000005110)
|
1061: prolonged, elevation of serun CCK
|
| 550 |
abnormal |
lipid metabolic process
(GO:0006629)
|
|
1060: Alteration, lipid metabolism
|
| 549 |
decreased |
|
bile
(UBERON:0001970)
|
1058: Decreased, bile flow
|
| 548 |
increased |
|
Granular Cell Tumor
(MESH:D016586)
|
1054: Promotion, ovarian granular cell tumors
|
| 547 |
increased |
hyperplasia
(MESH:D006965)
|
epithelium of female gonad
(UBERON:0004911)
|
1052: Hyperplasia, ovarian epithelium
|
| 546 |
increased |
hyperplasia
(MESH:D006965)
|
stromal cell of ovary
(CL:0002132)
|
1051: Hyperplasia, ovarian stromal cells
|
| 545 |
decreased |
follicle-stimulating hormone secretion
(GO:0046884)
|
Follicle stimulating hormone
(CHEBI:81569)
|
1049: Increased, secrection of FSH from anterior pituitary
|
| 544 |
decreased |
|
estradiol
(CHEBI:23965)
|
1045: Decreased, Ovarian E2
|
| 543 |
increased |
|
leiomyoma
(MESH:D007889)
|
1044: Promotion, mesovarian leiomyomas
|
| 542 |
increased |
hypertrophy
(MESH:D006984)
|
smooth muscle tissue
(UBERON:0001135)
|
1043: Hypertrophy/hyperplasia, smooth muscle
|
| 541 |
increased |
cell proliferation
(GO:0008283)
|
smooth muscle cell
(CL:0000192)
|
1042: Proliferation/Clonal Expansion, smooth muscle
|
| 540 |
increased |
relaxation of smooth muscle
(GO:0044557)
|
|
1040: relaxation, smooth muscle
|
| 539 |
increased |
beta2-adrenergic receptor activity
(GO:0004941)
|
beta-2 adrenergic receptor
(PR:000001193)
|
1039: Increased activity, beta-2 adrenergic receptor
|
| 538 |
increased |
beta-2 adrenergic receptor binding
(GO:0031698)
|
beta-2 adrenergic receptor
(PR:000001193)
|
1038: Activation, beta-2 adrenergic receptor
|
| 537 |
increased |
|
hemangiosarcoma
(MESH:D006394)
|
1037: Increased, hemagiosarcoma
|
| 536 |
increased |
|
liposarcoma
(MESH:D008080)
|
1036: Increased, liposarcoma
|